Logo
Login
$OMER
$17.49 +$1.20 (7.37%) Close

Company Executives

$OMER Management Team

Mr. Peter Williams

Vice President - Human Resources

Age 57
Compensation -
Sex Male

Mr. David Ghesquiere

Vice President

Chief Business Development Officer

Age 58
Compensation -
Sex Male

Dr. J. Steven Whitaker

Vice President - Clinical Development

Age 69
Compensation -
Sex Male

Dr. Gregory Demopulos

Chairman of the Board

President

Chief Executive Officer

Age 66
Compensation $3.764M USD
Sex Male

Mr. David Borges

Chief Accounting Officer

Vice President - Finance

Treasurer

Age 61
Compensation $627.9K USD
Sex Male

Dr. George Gaitanaris

Vice President - Science

Chief Scientific Officer

Age 68
Compensation -
Sex Male

Mr. Peter Cancelmo

Vice President

General Counsel

Secretary

Age 46
Compensation $906.9K USD
Sex Male

Ms. Nadia Dac

Vice President

Chief Commercial Officer

Age 55
Compensation -
Sex Female

Dr. Mariana Dimitrova

Vice President - Chemistry

Manufacturing and Controls

Age 59
Compensation -
Sex Female

Dr. Andreas Grauer

Vice President

Chief Medical Officer

Age 64
Compensation -
Sex Male

Dr. Catherine Melfi

Vice President - Regulatory Affairs and Quality Systems

Chief Regulatory Officer

Age 66
Compensation -
Sex Female

Board of Directors

From the proxy statement filed Apr 30, 2026
Directors
8
serving now
Independent
6 of 8
stated in the proxy
Average tenure
19.2 years
from year joined
CEO also chairs the board
Yes
Gregory A. Demopulos, M.D.
Director Age On board Independent Committees Other public boards Pay Source
Thomas J. Cable
Lead independent director
 86 1995
31 years
 Independent
Nominating and Governance · Chair
None stated Not stated
Peter A. Demopulos, M.D.
72 1995
31 years
 Not independent
Scientific
None stated Not stated
Diana T. Perkinson, M.D.
72 2023
3 years
 Independent
Scientific
None stated Not stated
Thomas F. Bumol, Ph.D.
72 2019
7 years
 Independent
Scientific · Chair
None stated Not stated
Gregory A. Demopulos, M.D.
CEO, Board chair
 67 1994
32 years
 Not independent None stated Smead Funds Trust Paid as CEO
Leroy E. Hood, M.D., Ph.D.
87 2001
25 years
 Independent
Compensation
None stated Not stated
Arnold C. Hanish
78 2012
14 years
 Independent
Audit · Chair
None stated Not stated
Rajiv Shah, M.D.
53 2015
11 years
 Independent
Audit Compensation Scientific
None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

2 disclosed in the proxy filed Apr 30, 2026
Gregory A. Demopulos, M.D.
Amount not stated

Technology transfer agreements under which he irrevocably transferred to us his intellectual property rights in the PharmacoSurgery platform and former Chondroprotective program, with a repurchase right on certain liquidations.

Open in proxy
Directors and executive officers
Amount not stated

Indemnification agreements providing for indemnification of expenses, judgments, fines and settlements relating to their service to the company.

Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans